Varivax vaccine with diluents
Ended Awarded Last action
- Contract number
- SPE2D325F289Q
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $23,706
Award facts
- Contract value 100% obligated
- $23,706.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency's Medical Supply Chain division awarded a firm fixed-price delivery order valued at $23,706.40 to DMS Pharmaceutical Group Inc. for Varivax vaccine with diluents. The award, issued on August 5, 2025, with an ultimate completion date of August 8, 2025, was made without a set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, serves as a critical supplier within the federal pharmaceutical supply chain, particularly for Department of Defense medical operations.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency, designated SPE2DR under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative. The underlying contract, valued at $499,999,999 with a completion date of December 31, 2036, positions the contractor as a regional prime vendor within the broader $30.3 billion PPV-G GEN V acquisition strategy. The contract authorizes the issuance of firm fixed-price delivery orders for comprehensive pharmaceutical products and medical consumables to support Department of Defense military healthcare facilities worldwide, with DMS Pharmaceutical Group's established performance demonstrating its capability to fulfill the specialized pharmaceutical requirements of the federal military medical system.
Quick answers
Who was awarded contract SPE2D325F289Q?
SPE2D325F289Q was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on August 5, 2025.
How much is contract SPE2D325F289Q worth?
The government has obligated $23,706 on SPE2D325F289Q.
Is contract SPE2D325F289Q an order under another contract?
Yes. SPE2D325F289Q is a delivery order under SPE2D021DA002, an indefinite delivery contract.
Was contract SPE2D325F289Q competed?
The extent of competition for SPE2D325F289Q was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award